Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2191]
News [5868]
Articles [116]
Editorials [31]
Conferences [186]
elearning [22]
Alectinib provides longer symptom improvement than crizotinib in ALK-positive lung cancer
Alectinib provides longer symptom improvement than crizotinib in ALK-positive lung cancer
Further evidence that immunotherapy provides a long-term survival benefit for lung cancer patients
Further evidence that immunotherapy provides a long-term survival benefit for lung cancer patients
NCI study revises molecular classification for most common type of lymphoma
NCI study revises molecular classification for most common type of lymphoma
Novel drug shows promise against acute myeloid leukaemia
Novel drug shows promise against acute myeloid leukaemia
Training the immune system to fight ovarian cancer
Training the immune system to fight ovarian cancer
Study reveals every bowel tumour and bowel cancer cell have unique genetic fingerprints
Study reveals every bowel tumour and bowel cancer cell have unique genetic fingerprints
New class of drugs could help tackle treatment-resistant cancers
New class of drugs could help tackle treatment-resistant cancers
An advance for precision medicine
An advance for precision medicine
Pembrolizumab improves OS as first-line therapy in advanced NSCLC expressing <1% PD-L1 on tumours
Pembrolizumab improves OS as first-line therapy in advanced NSCLC expressing
Turning up the heat on resistant tumours with novel immunotherapies
Turning up the heat on resistant tumours with novel immunotherapies

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation